Cross-institution positioning
Aug 14, 2026Reduction leaning. 1 accumulating, 1 reducing across 2 comparable institutions.
Source: Schedule 13 researchKMTS Institutional Ownership
KESTRA MEDICAL TECHNOLOGIES, LTD.
Latest stored close $26.98 as of Oct 9, 2026 View live quote ↗
STOCKNODE Outlook
Neutral
40/100
2 tracked · 2 comparable
Latest filing
Aug 14, 2026
Positive breadth
1 positive · 1 negative
Recent close
$26.98
Research confidence
Medium
Institutional Research 31/100 · 1 accumulating · 1 reducing / exited
Ownership history
Reported ownership % history
Latest filing Aug 14, 2026
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
Locked preview
Unlock the reported ownership timeline
Unlock full research
Accumulating1
Newly reported0
Reducing / exited
1
52-week position
—
Institutional Intelligence
Why STOCKNODE says Neutral
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
STOCKNODE Outlook
Neutral 40/100
Confidence:Medium
Why this signal
- 1 tracked institution accumulating versus 1 reducing/exited.
- Latest comparable Form 13F activity is net positive across tracked managers.
Institutional
43/100
Insiders
22/100
Fundamentals
44/100
Events
50/100
Quarterly 13F activity
Jun 30, 20262 increased/new, 0 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsInsider filing activity
Sep 30, 2026Over the last 90 days, SEC-coded non-derivative P/S activity includes 0 purchases by 0 reporting owners and 34 sales by 11 reporting owners. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/5Material company events
Sep 14, 20263 non-amendment material events in the last 90 days; 1 capital-related filing/event (0 equity-related, 1 debt-related); Latest classified evidence: Results of operations / financial condition. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataSEC fundamentals
Sep 14, 2026Revenue +59.9% YoY; Net income -70.7% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsPrice context
Sep 15, 2026Recent close is 62% through its reported 52-week range; +11.0% over one year.
Source: Stored historical price series
Latest filing decision brief
Investor / Pro
Research the latest Schedule 13G amendment from T. Rowe Price Associates.
Filed Aug 14, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
Supporting institutional evidence
Institutional Evidence
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
Latest filing
Aug 14, 2026
Latest reported position changes
Investor / Pro detailSee each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Fidelity / FMR
Filed Oct 7, 2025
Direction locked
T. Rowe Price Associates
Filed Aug 14, 2026
Direction locked
Unlock the actual direction, share change, ownership change, and classification basis.
No premium position values are sent in this locked preview.
Unlock full research
Reported direction breadth by as-of date
Locked previewComparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Unlock actual accumulation vs. reduction breadth across reported position dates.
View plans
Institution comparison
Investor / Pro detailCompare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Fidelity / FMR
Filed Oct 7, 2025
T. Rowe Price Associates
Filed Aug 14, 2026
Unlock the evidence behind the score
Know who changed position, by how much, and when the SEC learned about it.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
✓ Actual share and ownership changes
✓ Position as-of date vs. SEC filed date
✓ Deterministic direction basis
✓ Full evidence on every eligible stock
SEC Forms 3, 4 & 5
Insider activity
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
30-day purchases00 reporting owner(s)
30-day sales66 reporting owner(s)
90-day purchase breadth0
90-day sale breadth11Multi-insider
View recent insider filing evidence
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | COHEN RAYMOND W | SOpen-market or private sale | Common Shares | 3.3K | $29.28 | Direct | Oct 1, 2026 |
| Sep 21, 2026 | Kwo Elizabeth | SOpen-market or private sale | Common Shares | 4.0K | $24.26 | Direct | Sep 23, 2026 |
| Sep 9, 2026 | Schwartz Jeffrey Lawrence | AGrant, award, or other acquisition | Common Shares | 7.2K | — | Direct | Sep 10, 2026 |
| Sep 9, 2026 | Ladone Mary Kay | AGrant, award, or other acquisition | Common Shares | 7.2K | — | Direct | Sep 10, 2026 |
| Sep 9, 2026 | Reilly Kevin C | AGrant, award, or other acquisition | Common Shares | 7.2K | — | Direct | Sep 10, 2026 |
| Sep 9, 2026 | Hanley Conor | AGrant, award, or other acquisition | Common Shares | 7.2K | — | Direct | Sep 10, 2026 |
| Sep 9, 2026 | COHEN RAYMOND W | AGrant, award, or other acquisition | Common Shares | 7.2K | — | Direct | Sep 10, 2026 |
| Sep 9, 2026 | Kwo Elizabeth | AGrant, award, or other acquisition | Common Shares | 7.2K | — | Direct | Sep 10, 2026 |
| Sep 8, 2026 | Schwartz Jeffrey Lawrence | SOpen-market or private sale | Common Shares | 3.9K | $25.18 | Direct | Sep 10, 2026 |
| Sep 8, 2026 | Ladone Mary Kay | SOpen-market or private sale | Common Shares | 3.9K | $25.20 | Direct | Sep 10, 2026 |
| Sep 8, 2026 | Reilly Kevin C | SOpen-market or private sale | Common Shares | 2.9K | $25.13 | Direct | Sep 10, 2026 |
| Sep 8, 2026 | Hanley Conor | SOpen-market or private sale | Common Shares | 5.7K | $25.25 | Direct | Sep 10, 2026 |
| Aug 17, 2026 | Webster Brian Daniel | SOpen-market or private sale | Common Shares | 15.0K | $27.48 | Direct | Aug 18, 2026 |
| Aug 7, 2026 | Mahboob Vaseem | SOpen-market or private sale | Common Shares | 500 | $26.33 | Direct | Aug 11, 2026 |
| Aug 7, 2026 | Mahboob Vaseem | SOpen-market or private sale | Common Shares | 25.8K | $25.87 | Direct | Aug 11, 2026 |
| Aug 4, 2026 | Ford Alfred J Jr | SOpen-market or private sale | Common Shares | 6.3K | $24.09 | Direct | Aug 6, 2026 |
| Aug 4, 2026 | Mahboob Vaseem | SOpen-market or private sale | Common Shares | 3.9K | $25.17 | Direct | Aug 6, 2026 |
| Aug 4, 2026 | Mahboob Vaseem | SOpen-market or private sale | Common Shares | 3.1K | $24.06 | Direct | Aug 6, 2026 |
| Aug 4, 2026 | Umberger Traci S | SOpen-market or private sale | Common Shares | 3.6K | $24.04 | Direct | Aug 6, 2026 |
| Aug 4, 2026 | Webster Brian Daniel | SOpen-market or private sale | Common Shares | 442 | $25.98 | Direct | Aug 6, 2026 |
SEC company-event context
Material company events
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
30-day material events2
90-day capital-related1
90-day equity-related0
90-day debt-related1
View recent company-event filing evidence
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Sep 14, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Sep 10, 2026 | 8-K | 5.07 | Shareholder vote results | — | Filing |
| Jul 14, 2026 | 8-K | 1.01, 1.02, 2.02, 2.03, 9.01 | Material definitive agreement; Termination of material agreement; Results of operations / financial condition; New direct financial obligation; Financial statements / exhibits | Debt | Filing |
| Apr 1, 2026 | S-3ASR | — | Shelf securities registration | Capital-related | Filing |
| Mar 18, 2026 | S-8 | — | Employee-plan securities registration | Equity | Filing |
| Mar 17, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Dec 11, 2025 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Dec 4, 2025 | 8-K | 1.01, 9.01 | Material definitive agreement; Financial statements / exhibits | — | Filing |
| Dec 3, 2025 | 424B4 | — | Prospectus filing | Capital-related | Filing |
| Dec 1, 2025 | S-1 | — | Securities registration statement | Capital-related | Filing |
| Dec 1, 2025 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Nov 10, 2025 | 8-K | 7.01, 9.01 | Regulation FD disclosure; Financial statements / exhibits | — | Filing |
SEC-reported company fundamentals
Fundamentals
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
Revenue
$31.0M
Q1 2026
+59.9% YoY 10-Q filed Sep 14, 2026
Operating income
$-37.7M
Q1 2026
-30.4% YoY 10-Q filed Sep 14, 2026
Operating margin
-121.6%
Q1 2026
+27.5 pts YoY 10-Q filed Sep 14, 2026
Net income
$-44.1M
Q1 2026
-70.7% YoY 10-Q filed Sep 14, 2026
Diluted EPS
$-0.75
Q1 2026
-50.0% YoY 10-Q filed Sep 14, 2026
Operating cash flow
$-32.3M
Q1 2026
-22.9% YoY 10-Q filed Sep 14, 2026
Free cash flow
$-40.6M
Q1 2026
-18.0% YoY 10-Q filed Sep 14, 2026
Cash & equivalents
$68.6M
As of Jul 31, 2026
-65.9% YoY 10-Q filed Sep 14, 2026
Assets
$347.4M
As of Jul 31, 2026
+30.4% YoY 10-Q filed Sep 14, 2026
Liabilities
$125.0M
As of Jul 31, 2026
+52.2% YoY 10-Q filed Sep 14, 2026
Stockholders’ equity
$222.4M
As of Jul 31, 2026
+20.7% YoY 10-Q filed Sep 14, 2026
Shares outstanding
59.6M
As of Sep 11, 2026
+15.8% YoY 10-Q filed Sep 14, 2026
View recent revenue trend
Quarterly
| Period | Revenue | YoY |
|---|---|---|
| Ended Jul 31, 2026 | $31.0M | +59.9% |
| Ended Jan 31, 2026 | $24.6M | +62.7% |
| Ended Oct 31, 2025 | $22.6M | +53.4% |
| Ended Jul 31, 2025 | $19.4M | +51.5% |
Annual
| Period | Revenue | YoY |
|---|---|---|
| Ended Apr 30, 2026 | $95.1M | +59.0% |
| Ended Apr 30, 2025 | $59.8M | +115.1% |
| Ended Apr 30, 2024 | $27.8M | — |
Current market context
Price performance
Dated price context from the historical market series already collected for this security.
Recent stored close
$25.18
View live quote ↗
52-week low
$17.34
Apr 13, 2026
52-week high
$30.00
Oct 27, 2025
Below 52-week high
16.1%
1W return
-1.8%
1M return
-10.1%
3M return
+23.4%
6M return
+32.0%
YTD return
-5.1%
1Y return
+11.0%
30-day volatility
49.8%
90-day volatility
63.4%
1Y max drawdown
-36.2%
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
How to read Schedule 13 ownership changes
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
Current ownership filings and reported ownership changes are available on free access. Investor and Pro add filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and alerts. The overall institutional consensus preview remains public. Compare plans.
Beneficial ownership filing history
Showing 3 of 7 filing(s) · 4 older require more history accessView beneficial ownership filing evidence
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| T. Rowe Price Associates CIK0000080255 | Jun 30, 2026 observed Aug 14, 2026 filed · 45d Schedule 13G amendment | Reported reduction | 5.0M -999.8K | 8.50% -3.50 pts | $25.44 | $28.02 | $26.98 |
| T. Rowe Price Associates CIK0000080255 | Mar 31, 2026 observed Apr 8, 2026 filed · 8d Schedule 13G amendment | Reported accumulation | 6.0M +1.6M | 12.00% 0.00 pts | $19.93 | $19.62 | $26.98 |
| T. Rowe Price Associates CIK0000080255 | Dec 31, 2025 observed Feb 17, 2026 filed · 48d Initial Schedule 13G | Initial Schedule 13G | 4.4M | 12.00% | $26.52 | $26.08 | $26.98 |
Explore more institutional activity
Related research
Compare KMTS with other securities showing similar institutional activity or recent accumulation across several tracked institutions.